Maze Therapeutics (MAZE) Shares Outstanding (Weighted Average) (2024 - 2026)

Maze Therapeutics' Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $53.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 88.26% year-over-year to $53.9 million; the TTM figure through Mar 2026 stood at $53.9 million (up 88.26% YoY), while the FY2025 annual figure was $43.0 million, up 1693.59% from the prior year.
• Shares Outstanding (Weighted Average) came in at $53.9 million for Q1 2026 at Maze Therapeutics, up from $43.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $53.9 million in Q1 2026 to a low of $2.3 million in Q1 2024.
• A 3-year average of $24.1 million and a median of $28.6 million in 2025 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 1820.19% in 2025 and jumped 88.26% in 2026, its largest moves.
• Maze Therapeutics' Shares Outstanding (Weighted Average) stood at $2.4 million in 2024, then soared by 1693.59% to $43.0 million in 2025, then grew by 25.41% to $53.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $53.9 million, $43.0 million, and $45.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison